Ziemssen F - Search Results

1

A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.

Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, Kubisch C, Schoser BG, Mortier W. Vorgerd M, et al. Among authors: ziemssen f. Neurology. 2001 Dec 26;57(12):2273-7. doi: 10.1212/wnl.57.12.2273. Neurology. 2001. PMID: 11756609

2

Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.

Ziemssen F, Sindern E, Schröder JM, Shin YS, Zange J, Kilimann MW, Malin JP, Vorgerd M. Ziemssen F, et al. Ann Neurol. 2000 Apr;47(4):536-40. Ann Neurol. 2000. PMID: 10762170

3

Adult polyglucosan body disease: a postmortem correlation study.

Sindern E, Ziemssen F, Ziemssen T, Podskarbi T, Shin Y, Brasch F, Müller KM, Schröder JM, Malin JP, Vorgerd M. Sindern E, et al. Among authors: ziemssen t, ziemssen f. Neurology. 2003 Jul 22;61(2):263-5. doi: 10.1212/01.wnl.0000073144.96680.cb. Neurology. 2003. PMID: 12874416

4

Dynamic formation of macular microcysts independent of vitreous traction changes.

Ziemssen F, Ziemssen T, Brandt AU, Lagrèze WA. Ziemssen F, et al. Among authors: ziemssen t. Neurology. 2015 Jan 27;84(4):436-7. doi: 10.1212/01.wnl.0000460819.78400.df. Neurology. 2015. PMID: 25628434 No abstract available.

5

Perspectives of an innovative ophthalmological technology: optical coherence tomography (OCT)--what should be of interest to the neurologist?

Ziemssen T, Ziemssen F. Ziemssen T, et al. Among authors: ziemssen f. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S55-9. doi: 10.1016/j.clineuro.2013.09.022. Clin Neurol Neurosurg. 2013. PMID: 24321156 Review.

6

The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).

Ziemssen T, Ziemssen F. Ziemssen T, et al. Among authors: ziemssen f. Autoimmun Rev. 2005 Sep;4(7):460-7. doi: 10.1016/j.autrev.2005.03.005. Autoimmun Rev. 2005. PMID: 16137612 Review.

7

[Multiple sclerosis. An update with practical guidelines for ophthalmologists].

Ziemssen T, Wilhelm H, Ziemssen F. Ziemssen T, et al. Among authors: ziemssen f. Ophthalmologe. 2006 Jul;103(7):621-41; quiz 642-3. doi: 10.1007/s00347-006-1368-x. Ophthalmologe. 2006. PMID: 16819666 German.

8

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators. Cadavid D, et al. Among authors: ziemssen t, ziemssen f. Lancet Neurol. 2017 Mar;16(3):189-199. doi: 10.1016/S1474-4422(16)30377-5. Epub 2017 Feb 15. Lancet Neurol. 2017. PMID: 28229892 Clinical Trial.

9

Intravitreous bevacizumab and blood pressure: does 'safe' mean 'safe enough'?

Ziemssen F, Folprecht G, Ziemssen T. Ziemssen F, et al. Among authors: ziemssen t. Acta Ophthalmol Scand. 2007 Aug;85(5):573-4; author reply 574-5. doi: 10.1111/j.1600-0420.2007.00938.x. Epub 2007 Apr 30. Acta Ophthalmol Scand. 2007. PMID: 17474969 Free article. No abstract available.

10

Predictors of response to opicinumab in acute optic neuritis.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators. Cadavid D, et al. Among authors: ziemssen t, ziemssen f. Ann Clin Transl Neurol. 2018 Aug 15;5(10):1154-1162. doi: 10.1002/acn3.620. eCollection 2018 Oct. Ann Clin Transl Neurol. 2018. PMID: 30349850 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters